Pharmacokinetic and Bioequivalence Study of Telzap AM® (Telmisartan/amlodipine Fixed-dose Combination) and Coadministered Mikardis® (Telmisartan) and Norvask® (Amlodipine) in Healthy Subjects

Introduction. A fixed dose combination of telmisartan and amlodipine is widely used in clinical practice during hypertension treatment. Combination of telmisartan and amlodipine demonstrates potentiating synergistic effect on blood pressure decrease. A bioequivalence study of Telzap® AM with coadmin...

Descripció completa

Guardat en:

Dades bibliogràfiques
Autors principals:	V. Kubesh, A. L. Khokhlov, A. M. Shitova, Yu. A. Dzhurko, V. I. Kazey, A. A. Khokhlov, A. E. Miroshnikov, O. V. Lebedeva, I. K. Klaus, A. V. Zyatenkov
Format:	Artigo
Idioma:	Russo
Publicat:	LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2020-11-01
Col·lecció:	Разработка и регистрация лекарственных средств
Matèries:	telmisartan amlodipine pharmacokinetics bioequivalence
Accés en línia:	https://www.pharmjournal.ru/jour/article/view/824
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Pharmacokinetic and Bioequivalence Study of Telzap AM<sup>®</sup> (Telmisartan/amlodipine Fixed-dose Combination) and Coadministered Mikardis<sup>®</sup> (Telmisartan) and Norvask<sup>®</sup> (Amlodipine) in Healthy Subjects

Ítems similars